Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Mesenchymal Cells for Severe COVID-19 Pneumonia
NCT04366271Phase 2Withdrawn
- Sponsor
- Hospital Universitario Niño Jesús
- Start
- May 2020
- Primary completion
- Jul 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in COVID-19 pneumonia, sponsored by Hospital Universitario Niño Jesús. Planned start May 2020; status: withdrawn.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04366271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04366271.